scispace - formally typeset
H

Hiroshi Hasegawa

Researcher at Tokyo University of Pharmacy and Life Sciences

Publications -  90
Citations -  1713

Hiroshi Hasegawa is an academic researcher from Tokyo University of Pharmacy and Life Sciences. The author has contributed to research in topics: Methionine & Homocysteine. The author has an hindex of 18, co-authored 90 publications receiving 1580 citations. Previous affiliations of Hiroshi Hasegawa include University of Tokyo.

Papers
More filters
Journal ArticleDOI

Changes in muscle size, architecture, and neural activation after 20 days of bed rest with and without resistance exercise.

TL;DR: The results suggest that reduction of muscle strength by BR is affected by a decreased ability to activate motor units, and that the exercise used in the present experiment is effective as a countermeasure.
Journal ArticleDOI

Dynamical Properties of s-d Interaction

TL;DR: In this article, the authors investigated the dynamical properties of two spin systems composed of conduction electron spins and localized d-spins interacting by exchange in connection with the electron-spin resonance of d-spin with the free electron g-value.
Journal ArticleDOI

Microscopic Theory of the Temperature-Pressure Phase Diagram of Iron

TL;DR: The free energy of bcc, fcc, and hcp iron has been calculated as a function of temperature and pressure within the single-site spin-fluctuation theory of band magnetism, which has been developed recently by Hubbard and Hasegawa.
Journal ArticleDOI

Quantum Theory of Galvanomagnetic Effect. I. Basic Considerations

TL;DR: In this article, a quantum-mechanical theory of galvanomagnetic effect is developed on the basis of the general theory of irreversible processes previously reported by Kubo (J. Phys. Soc. Japan 12 (1957) 570).
Journal ArticleDOI

Liver-specific distribution of rosuvastatin in rats: comparison with pravastatin and simvastatin.

TL;DR: The results of this study indicated that rosuvastatin was taken up by hepatic cells more selectively and more efficiently than pravastatin and simVastatin.